Develop A Regenerative Technology To Potentially Cure Type 1 Diabetes Without The Need For Chronic Immuno-suppression

KADIMASTEM LTD. Israel has Released a tender for Develop A Regenerative Technology To Potentially Cure Type 1 Diabetes Without The Need For Chronic Immuno-suppression in . The tender was released on Jan 01, 1970.

Country - Israel

Summary - Develop A Regenerative Technology To Potentially Cure Type 1 Diabetes Without The Need For Chronic Immuno-suppression

Deadline - Dec 31, 2024

IT reference number - 10839344

Product classification -

Organization Details:

  Address - Israel

  Contact details - 565656565

  Tender notice no. - 76454545

  IT Ref Id - 10839344

  Document Type - Tender Notices

Login

Notice Details and Documents:

Description - Scope ; Kadimastem Ltd. (Ness Ziona, Israel), and iTolerance (Miami, FL) who will develop a regenerative technology to potentially cure type 1 diabetes without the need for chronic immuno-suppression. IT Tenders is not only confined to tenders but we also upload crucial information, from future prospects to past market records.

It Ref Id - 10839344

Deadline - Dec 31, 2024

Login

Share

View more tenders for

Israel Tenders
Most Searched